Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
CareDx, Inc., et al. v. Natera, Inc.
Case Number:
1:19-cv-00567
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
September 29, 2021
Del. Judge Invalidates Stanford Kidney Test Patents
A Delaware federal judge has determined that three Stanford University patents licensed to a developer of commercial tests for kidney transplant rejections are invalid, finding the claims at issue weren't eligible for patent protection.
-
December 02, 2020
Del. Judge Keeps Alive Stanford IP Suits Over Kidney Test
A battle over alleged infringements of three licensed Stanford University patents by developers of commercial tests for kidney transplant rejections moved toward trial Tuesday after a Delaware district judge rejected summary judgment claims of invalidity by alleged infringers Natera Inc. and Eurofins Viracor Inc.
-
March 26, 2019
Natera Infringing Transplant Testing Patents, Stanford Says
Natera is infringing two Stanford University patents covering a noninvasive method of testing if transplanted organs are being rejected, the school alleged Tuesday in Delaware federal court.